Free Trial
TSE:RVX

Resverlogix 11/12/2024 Earnings Report

Resverlogix logo
C$0.04 +0.01 (+14.29%)
As of 01:01 PM Eastern

Resverlogix EPS Results

Actual EPS
-C$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Resverlogix Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Resverlogix Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Resverlogix Earnings Headlines

Trump Treasure April 19
Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…
Resverlogix Corp. (RVXCF)
See More Resverlogix Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Resverlogix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Resverlogix and other key companies, straight to your email.

About Resverlogix

Resverlogix (TSE:RVX) Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.

View Resverlogix Profile

More Earnings Resources from MarketBeat